The University of Texas MD Anderson Cancer Center

12th Oncology Update:

Advances and Controversies
January 17–20, 2014
...
EDUCATIONAL METHODS	

Lectures - Question and Answer Sessions – Case Presentations – Meet the Professor Sessions

EVALUATI...
Program

Saturday, January 18, 2014
6:30 a.m.	 Registration/Continental Breakfast

Session II – Melanoma
Moderator: Merric...
Sunday, January 19, 2014
6:30 a.m.	 Registration/Continental Breakfast

Session IV – Urology
Moderator: Christopher G. Woo...
MD AndersonFaculty
David M. Adelman, MD
Assistant Professor
Plastic Surgery

Jeffrey E. Lee, MD
Chair & Professor
Surgical...
Fellows, Physician Assistants,
Nurses, Social Workers
1 Postmarked before 1/3/14.................$250.00
1 Postmarked afte...
Department of CME/Conference Management - Unit 1381
The University of Texas MD Anderson Cancer Center
#176700/D111465/PS10...
Upcoming SlideShare
Loading in …5
×

12th Oncology Update: Advances and Controversies

604 views

Published on

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
604
On SlideShare
0
From Embeds
0
Number of Embeds
13
Actions
Shares
0
Downloads
5
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

12th Oncology Update: Advances and Controversies

  1. 1.  The University of Texas MD Anderson Cancer Center 12th Oncology Update: Advances and Controversies January 17–20, 2014 Sheraton Steamboat Hotel Steamboat Springs, Colorado
  2. 2. EDUCATIONAL METHODS Lectures - Question and Answer Sessions – Case Presentations – Meet the Professor Sessions EVALUATION 12th Oncology Update: Advances and Controversies January 17-20, 2014 Sheraton Steamboat Hotel • Steamboat Springs, Colorado GOAL The goal of this program is to provide up-to-date information to the practicing physician regarding new advances in cancer care and treatment. EDUCATIONAL OBJECTIVES After attending the conference, participants should be able to • Interpret information and incorporate into treatment the best novel therapies for solid tumors including Breast, Thoracic, Genitourinary, Gastrointestinal, Gynecologic/Peritoneal Malignancies, Head & Neck Cancer and Melanoma (Knowledge, Competence, Performance, Patient Outcomes) • Utilize different surgical, radiation, and systemic treatments including molecularly targeted therapies for these cancers at various stages of disease to improve patient outcomes (Knowledge, Competence, Performance, Patient Outcomes) • Incorporate appropriate sequence for surgical, radiation, and chemotherapeutic intervention for patients (Knowledge, Competence, Performance, Patient Outcomes) • Illustrate and implement the optimal treatment approach when given patient scenarios representing a range of stages, prognostic markers, and clinical presentations (Knowledge, Competence, Performance, Patient Outcomes) • Interpret the clinical effectiveness of the different treatment modalities based upon efficacy and toxicity parameters (Knowledge, Competence, Performance, Patient Outcomes) TARGET AUDIENCE This program will be of interest to surgical oncologists, medical oncologists, radiation oncologists, diagnostic radiologists, pathologists, resident trainees, primary care physicians, advanced care practitioners, physician assistants, and nurses involved in oncologic care. A course evaluation form will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics. ACCREDITATION/CREDIT DESIGNATION The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 25.50 AMA PRA Category 1 CreditsTM. Physicians should claim only credit commensurate with the extent of their participation in the activity. ETHICS CREDITS Session VI presentations marked with an asterisk* have been designated by The University of Texas MD Anderson Cancer Center for a total of 2.50 AMA PRA Category 1 CreditsTM in medical ethics and/or professional responsibility. CME CERTIFICATES AND ATTENDANCE VERIFICATION CERTIFICATES Certificates awarding AMA PRA Category 1 CreditTM or certificates documenting attendance will be distributed to participants when an individual departs the conference. To obtain a CME certificate, physicians must submit a completed evaluation questionnaire and a CME Verification Form. Upon request, a record of attendance (certificate) will be provided on-site to other health care professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations. CONFERENCE CHAIRMAN Merrick I. Ross, MD Professor, Surgical Oncology MD Anderson MD ANDERSON ORGANIZING COMMITTEE Rae Brana Reynolds, RN, MSN Manager, Mid-Level Provider, Surgical Oncology Cynthia A. Scott Office Manager, Surgical Oncology Constance Tierney, CMP Manager, CME/Conference Management
  3. 3. Program Saturday, January 18, 2014 6:30 a.m. Registration/Continental Breakfast Session II – Melanoma Moderator: Merrick I. Ross, MD Friday, January 17, 2014 3:00–5:00 p.m. Registration Session I – Thoracic Oncology Moderator: Stephen G. Swisher, MD 5:00 p.m. Current Recommendations for Lung Cancer Screening: Are We Making Any Progress? Stephen G. Swisher, MD Treatment of Primary Lung Cancer: Surgery or Stereotactic Radiation – What About the Mediastinum? David C. Rice, MD Update on the Battle Trial: Are We Winning Any Battles? John V. Heymach, MD Treating Lung Cancer with Immunotherapy and Radiation James Welsh, MD Minimally Invasive Approaches to Esophageal Cancer Wayne L. Hofstetter, MD Question and Answer/Case Presentations All Session Faculty Keynote Presentatons: Cancer Immunotherapy: Checkpoint Inhibition, Melanoma and Beyond Patrick Hwu, MD 8:00-10:00 p.m. Welcome Reception Prognostic Markers and Staging: What’s New? Jeffrey E. Gershenwald, MD Current Status of Adjuvant Therapy: Any Changes On the Horizon? Merrick I. Ross, MD Treatment of Stage IV Disease: The Art and Science of Decision Making Patrick Hwu, MD The conference will begin with registration from 3:00-5:00 p.m. on Friday, January 17, 2014 followed by a session from 5:00-8:00 p.m. and a Welcome Reception from 8:00-10:00 p.m. All other sessions will run from 7:00 a.m.–Noon and 4:30–7:30 p.m. on January 18-20, 2014. 7:00 Oncolytic Immunotherapy: Real Systemic Impact or Just Another Intra-Lesional Therapy? Robert H. Andtbacka, MD Reconstruction After Definitive Surgical Treatment David M. Adelman, MD Question and Answer/Case Presentations All Session Faculty 9:30 Break 10:00 Meet the Professor – Melanoma Surgical and Medical Oncologists Noon Session Adjourns Session III – Breast Cancer Moderator: Kelly K. Hunt, MD 4:30 p.m. The Art and Science of Genetic Counselng in Breast Cancer Jennifer Litton, MD Current Controversies in the Management of DCIS Kelly K. Hunt, MD Selective Use of Adjuvant Therapy: Have the New Markers Helped? Funda Meric-Bernstam, MD Update on Triple Negative and Inflammatory Breast Cancer Jennifer Litton, MD Recurrent HER-2 Breast Cancer: Beyond Trastuzimab Vicente Valero, MD Cancer Vaccines: Is There a Future? Elizabeth A. Mittendorf, MD Question and Answer/Case Presentations All Session Faculty Keynote Presentation: Molecular Prognostic and Predictive Markers: Is Personalized Therapy Around the Corner? Funda Meric-Bernstam, MD 7:30 p.m. Session Adjourns
  4. 4. Sunday, January 19, 2014 6:30 a.m. Registration/Continental Breakfast Session IV – Urology Moderator: Christopher G. Wood, MD 7:00 a.m. Management of the Primary Tumor in Advanced Prostate Cancer Brian F. Chapin, MD Localized Prostate Cancer: Who Really Needs Treatment? Neema Navai, MD Robotic Assisted Laparoscopic Radical Cystectomy with Intracorporeal Diversion: Fact, Fad, or Fantasy? Jay B. Shah, MD Controversies in the Management of Stage 1 Non-Seminomatous Testicular Cancer Jose A. Karam, MD Is there a Role for Neoadjuvant Therapy in the Management of Locally Advanced Renal Cell Carcinoma? Christopher G. Wood, MD Question and Answer/Case Presentations All Session Faculty 9:30 Break 10:00 Meet the Professor – Urology Faculty Noon Session Adjourns Session V – GI Cancer Moderator: Robert A. Wolff, MD 4:30 p.m. Systemic Therapy for Pancreas Cancer: Neo-Adjuvant or Adjuvant? Robert A. Wollf, MD Xenograft Models in Pancreas Cancer: Impact on Future Therapies Jason B. Fleming, MD Colon Cancer Prevention: Any Progress Made? Patrick Lynch, MD, JD Radiation Therapy for Rectal Cancer: Routine or Selective Use? Christopher Crane, MD Hepatocellular Cancer: Still a Death Sentence? Steven A. Curley, MD Question and Answer/Case Presentations All Session Faculty Keynote Presentation: Proton Therapy: Expensive Gimmick or Real Benefit? GU: Andrew K. Lee, MD Head & Neck: Steven J. Frank, MD 7:30 p.m. Session Adjourns Monday, January 20, 2014 6:30 a.m. Registration/Continental Breakfast Session VI – Outcomes and Ethics Moderator: Merrick I. Ross, MD 7:00 a.m. Outcome Parameters in Cancer Care* Karl Y. Bilimoria, MD Quality of Life Assessment in Treating Patients with Melanoma and Breast Cancer* Janice N. Cormier, MD Palliative Surgery: How Do We Measure Success?* Brian D. Badgwell, MD Cervical Cancer Vaccine: Efficacy and Should it be Mandatory? Kathleen M. Schmeler, MD Health Legislation/Policy Updates TBD Question and Answer – All Session Faculty Keynote Presentation: Update on Retroperitoneal Sarcomas: From Bench Research to the Patient Raphael E. Pollock, MD 9:30 Break 10:00 Meet The Professor – Sarcoma Faculty Noon Session Adjourns Session VII – Head and Neck/Brain Moderator: Michael E. Kupferman, MD 4:30 p.m. Epidemiology of HPV and Cancer Erich M. Sturgis, MD Update on HPV Related Head and Neck Cancer Michael E. Kupferman, MD Multidisciplinary Approach to Advanced Thyroid Cancer Jeffrey E. Lee, MD Management of Metastatic Brain Tumors: Surgery or Gamma Knife? Jeffrey Weinberg, MD Question and Answer – All Session Faculty Session VIII – Gynecologic/Peritoneal Malignancies Moderator: Michael Frumovitz, MD Using Social Media to Perform Research in Rare Tumors Jennifer K. Burzawa, MD Multidisciplinary Management of Ovarian Cancer Michael Frumovitz, MD Peritoneal Perfusion: Appendiceal Cancer and Beyond Richard Royal, MD Question and Answer/Case Presentations – All Session Faculty 7:30 p.m. Conference Adjournment
  5. 5. MD AndersonFaculty David M. Adelman, MD Assistant Professor Plastic Surgery Jeffrey E. Lee, MD Chair & Professor Surgical Oncology Brian D. Badgwell, MD Assistant Professor Surgical Oncology Jennifer Litton, MD Assistant Professor Breast Medical Oncology Jennifer K. Burzawa, MD Assistant Professor Gynecologic Oncology Reproductive Medicine Patrick M. Lynch, MD, JD Professor, Gastroenterology Hepatology & Nutrition Brian F. Chapin, MD Assistant Professor Urology Janice N. Cormier, MD Professor Surgical Oncology Christopher Crane, MD Professor Radiation Oncology Steven A. Curley, MD Professor Surgical Oncology Jason B. Fleming, MD Professor Surgical Oncology Steven J. Frank, MD Associate Professor Radiation Oncology Michael Frumovitz, MD Associate Professor Gynecologic Oncology Reproductive Medicine Jeffrey E. Gershenwald, MD Professor Surgical Oncology John V. Heymach, MD Chair & Associate Professor Thoracic/Head & Neck Medical Oncology Wayne L. Hofstetter, MD Associate Professor Thoracic & Cardiovascular Surgery Kelly K. Hunt, MD Professor Surgical Oncology Patrick Hwu, MD Professor Melanoma Medical Oncology Jose A. Karam, MD Assistant Professor Urology Michael E. Kupferman, MD Associate Professor Head & Neck Surgery Andrew K. Lee, MD Professor Radiation Oncology Funda Meric-Bernstam, MD Professor, Surgical Oncology Elizabeth A. Mittendorf, MD Assistant Professor Surgical Oncology Neema Navai, MD Assistant Professor Urology Victor G. Prieto, MD, PhD Professor Pathology Administration David C. Rice, MD Professor, Thoracic & Cardiovascular Surgery Merrick I. Ross, MD Professor Surgical Oncology REGISTRATION INFORMATION Guest Faculty Robert H. Andtbacka, MD Assistant Professor Division of Surgical Oncology University of Utah School of Medicine Huntsman Cancer Institute Salt Lake City, Utah Karl Y. Bilimoria, MD Assistant Professor, Surgery Northwestern University Feinberg School of Medicine Chicago, Illinois Raphael E. Pollock, MD Professor of Surgery Director of Surgical Oncology Chief of Surgical Services The Ohio State University The James Comprehensive Cancer Center Columbus, Ohio On-site registration for the 12th Annual Oncology Update: Advances and Controversies, will open at 3:00 pm on Friday, January 17, 2014, and the conference will begin at 5:00 pm on Friday, January 17, 2014, followed by a Welcome Reception. The conference will adjourn at 7:30 pm on Monday, January 20, 2014. Advance registration is encouraged as space and materials are limited. Please see registration form for applicable fees. The deadline for advance registration is January 3, 2014. There are three ways to register: • Mail to CME/Conference Management – Unit 1381, The University of Texas MD Anderson Cancer Center, P. O. Box 301439, Houston, TX 77230-1439. • Fax to 713-794-1724 • Register on-line at www.mdanderson.org/conferences We accept the following forms of payment: • Check (payable through U.S. banks only) • Money order • Credit cards (MasterCard, VISA, and American Express) • Cash (on-site registration only) When registering on-line a receipt/confirmation letter will automatically be e-mailed to the e-mail address you list on the registration form. If you register by fax or mail a receipt/ confirmation letter will be sent to you within ten working days of receipt of your fee. Richard Royal, MD Associate Professor Surgical Oncology The conference registration fee includes the tuition, final program, continental breakfasts, coffee breaks, and welcome reception. Kathleen M. Schmeler, MD Associate Professor Gynecologic Oncology & Reproductive Medicine REFUND/CANCELLATION POLICY Jay B. Shah, MD Assistant Professor Urology Stephen G. Swisher, MD Chair & Professor Thoracic & Cardiovascular Surgery Erich M. Sturgis, MD Professor Head & Neck Surgery Vicente Valero, MD Chair Ad Interim & Professor Breast Medical Oncology Jeffrey Weinberg, MD Associate Professor Neurosurgery James Welsh, MD Assistant Professor Radiation Oncology Robert A. Wolff, MD Chair Ad Interim & Professor Investigational Cancer Therapeutics Christopher G. Wood, MD Professor Urology The registration fee, minus a $50 administrative handling fee, is refundable if a written request is received on or before January 3, 2014. No refunds will be granted after that date. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check. For additional information, contact CME/Conference Management at 713-792-2223 or toll free at 866-849-5866. The University of Texas MD Anderson Cancer Center has implemented a process whereby everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest that could potentially affect the information presented. MD Anderson also requires that all faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products. Specific disclosure will be made to the participants prior to the educational activity. The Department of CME/Conference Management reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary. Each registrant will be notified by mail, e-mail, or the phone or fax numbers given on the registration form. In case of activity cancellation, the liability of the Department of CME/Conference Management is limited to the registration fee. The Department of CME/Conference Management reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. For additional information, contact CME/Conference Management at 713-792-2223 or 1-866-849-5866.
  6. 6. Fellows, Physician Assistants, Nurses, Social Workers 1 Postmarked before 1/3/14.................$250.00 1 Postmarked after 1/3/14....................$275.00 MD Anderson Faculty 1 Postmarked before 1/3/14.................$350.00 1 Postmarked after 1/3/14....................$375.00 Physicians 1 Postmarked before 1/3/14.................$550.00 1 Postmarked after 1/3/14....................$600.00 12th Oncology Update: Advances and Controversies, January 17–20, 2014 Rooms are guaranteed 30 days prior to arrival by taking a full deposit of the entrie stay. Upon the taking of the deposit all reservations are unchangeable. If cancelled the deposit is non-refundable. REGISTRATION FEES • Reservations and deposits received after December 18, 2013, will be confirmed if space is available and at currently published hotel guest room rates. Make check or money order payable to: The University of Texas MD Anderson Cancer Center • When you make reservations, be sure to mention the MD Anderson 12th Annual Oncology Update: Advances and Controversies Conference to be assured of receiving the special meeting rate of $239.00. Condos and suites are available. Call hotel for rates. Please add 11.65% state and local taxes. or fax to 713-794-1724 • Website: https://www.starwoodmeeting.com/StarGroupsWeb/res?id=1309053046&key=7D2F9 ADDRESS TO: • The hotel phone number is 1-800-848-8877 THIS IS NOT A SELF-MAILER • Early hotel reservation is suggested. 12th Oncology Update: Advances and Controversies • A block of rooms has been reserved for conference attendees at the Sheraton Steamboat Hotel, 2220 Village Inn Court, Steamboat Springs, Colorado. Department of CME/Conference Management–Unit 1381 The University of Texas MD Anderson Cancer Center PO Box 301439, Houston, TX 77230-1439 ACCOMMODATIONS Photographing, audio taping and videotaping are prohibited. IDT Approver E-mail IDT Approver Name (First/Last) please print Authorized Signature REQUIRED for credit card or IDT MD Anderson Employee ID No. (REQUIRED) Activity Project Business Unit Department Credit Card Number Fund Group Fund MD Anderson Interdepartmental Transfer (IDT) No.: Fund Type PC By Expiration Date Credit Card Holder Billing Address & ZIP Code Credit Card Holder Name (First/Last) Charge the following: oVISA oMasterCard oAmerican Express Phone (with area code) Emergency Contact E-mail Address Fax (with area code) Cell Phone (with area code) Daytime Phone (with area code) oNo State/Foreign Country/Zip or Mail Code MI oYes City Street Agendas are subject to change because we are always striving to improve the quality of your educational experience. MD Anderson may substitute faculty with comparable expertise on rare occasions necessitated by illness, scheduling conflicts, and so forth. Physician The University of Texas MD Anderson Cancer Center has implemented a process whereby everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest that could potentially affect the information presented. MD Anderson also requires that all faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products. Specific disclosure will be made to the participants prior to the educational activity. Institution Please let us know what specific topics, issues or questions you wish to see addressed or emphasized in this activity. Fax or e-mail CME/Conference Management. All responses will be forwarded to the Program Chairs for consideration. Specialty Contact the Department of CME/Conference Management at 713-792-2223 or 1-866-849-5866 if you have any special dietary or ADA accommodation needs. Department (include box no.) SPECIAL ASSISTANCE First The Sheraton Steamboat Hotel is 22 miles from the Yampa Valley Regional Airport in Hayden (locator code: HDN) and is served by United, Delta, Northwest, and American Airlines. Transportation from the Yampa Valley Regional Airport is available by GO Alpine Airport Shuttle at $35.20/person one way or $55.00/person round trip. Advance reservations are strongly suggested, since walk-up passengers are boarded on a space available basis only. Reservations can be made on-line up to 48 hours beforehand at www.alpinetaxi.com or by phone at 1-800-343-7433. 12th Oncology Update: Advances and Controversies – January 17–20, 2014 GROUND TRANSPORTATION CONFERENCE REGISTRATION - D111465/0658 • Lift ticket discount is 5%. Coupons will be available at registration. Last Name • Ski rentals are available for the group at a 30% discount. The code for the group is #SHMD. Website is: https://store.steamboat.com/estore_996/Default.aspx Highest Degree LIFT TICKETS/EQUIPMENT RENTAL
  7. 7. Department of CME/Conference Management - Unit 1381 The University of Texas MD Anderson Cancer Center #176700/D111465/PS100658 PO Box 301439 Houston, TX 77230-1439 Non-Profit Org. U.S. Postage PAID Houston, TX Permit No. 7052

×